Thiotepa and graft versus host disease Patient Reports March 21, 2010

Thiotepa Side Effects Report #6051075-8
Thiotepa side effect was reported by a Health Professional from ITALY on Jan 05, 2009. Female patient was diagnosed with bone marrow conditioning regimen, graft versus host disease, prophylaxis and was treated with Thiotepa. After drug was administered, patient experienced the following side effects: basal cell carcinoma, graft versus host disease, growth retardation, hypothyroidism, scleroderma . Thiotepa dosage: 10 MG/KG. During the same period patient was treated with MELPHALAN, CYCLOSPORINE, METHOTREXATE, PREDNISONE. Patient recovered.